Characterization of ACTN4 as a novel antiviral target against SARS-CoV-2
{{output}}
The various mutations in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pose a substantial challenge in mitigating the viral infectivity. The identification of novel host factors influencing SARS-CoV-2 replication holds potential for discovering ... ...
